| California Counseling Associates, A Licensed Professional Clinical Cou | |
|
1242 Park St Suite C Alameda CA 94501-5500 | |
| (510) 521-3500 | |
| Not Available |
| Full Name | California Counseling Associates, A Licensed Professional Clinical Cou |
|---|---|
| Speciality | Psychologist |
| Location | 1242 Park St, Alameda, California |
| Authorized Official Name and Position | Maria Napitan (OFFICE MANAGER/BILLING MANAGER) |
| Authorized Official Contact | 5108129410 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| California Counseling Associates, A Licensed Professional Clinical Cou 1242 Park St Suite C Alameda CA 94501-5500 Ph: (510) 521-3500 | California Counseling Associates, A Licensed Professional Clinical Cou 1242 Park St Suite C Alameda CA 94501-5500 Ph: (510) 521-3500 |
| NPI Number | 1407888779 |
|---|---|
| Provider Enumeration Date | 07/07/2006 |
| Last Update Date | 05/06/2024 |
| Certification Date | 05/06/2024 |
| Medicare PECOS PAC ID | 1658645247 |
|---|---|
| Medicare Enrollment ID | O20170920002359 |
News Archive
Methotrexate (MTX) is commonly used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.
Genes of one organism not only control the characteristics of that individual but also dictate the behavior of thousands of other organisms in a community.
Older people in Japan have an "attitude of gratitude" which keeps them feeling hopeful despite the challenges of aging, a new study says.
MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded as part of the Affordable Care Act, apply to small-company R&D expenditures that reduce the cost and increase the quality of healthcare in the U.S. The grants will be applied to the development of MicroPhage's first product, the MRSA/MSSA Blood Culture Test, currently under review at the FDA.
Avita Medical Ltd., the regenerative medicine company, announced today that it has launched ReCell Spray-On Skin for the treatment of chronic leg ulcers, a market estimated at over US$1 billion.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407888779 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY 9002 (California) | Primary |
| Provider Name | Debra Puryear |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1942463047 PECOS PAC ID: 9830465871 Enrollment ID: I20171023000531 |
News Archive
Methotrexate (MTX) is commonly used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.
Genes of one organism not only control the characteristics of that individual but also dictate the behavior of thousands of other organisms in a community.
Older people in Japan have an "attitude of gratitude" which keeps them feeling hopeful despite the challenges of aging, a new study says.
MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded as part of the Affordable Care Act, apply to small-company R&D expenditures that reduce the cost and increase the quality of healthcare in the U.S. The grants will be applied to the development of MicroPhage's first product, the MRSA/MSSA Blood Culture Test, currently under review at the FDA.
Avita Medical Ltd., the regenerative medicine company, announced today that it has launched ReCell Spray-On Skin for the treatment of chronic leg ulcers, a market estimated at over US$1 billion.
› Verified 9 days ago
| Provider Name | Emily E Muse |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1457558199 PECOS PAC ID: 2567738503 Enrollment ID: I20171023002339 |
News Archive
Methotrexate (MTX) is commonly used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.
Genes of one organism not only control the characteristics of that individual but also dictate the behavior of thousands of other organisms in a community.
Older people in Japan have an "attitude of gratitude" which keeps them feeling hopeful despite the challenges of aging, a new study says.
MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded as part of the Affordable Care Act, apply to small-company R&D expenditures that reduce the cost and increase the quality of healthcare in the U.S. The grants will be applied to the development of MicroPhage's first product, the MRSA/MSSA Blood Culture Test, currently under review at the FDA.
Avita Medical Ltd., the regenerative medicine company, announced today that it has launched ReCell Spray-On Skin for the treatment of chronic leg ulcers, a market estimated at over US$1 billion.
› Verified 9 days ago
| Provider Name | Taryn L Propersi |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1326297466 PECOS PAC ID: 0244480549 Enrollment ID: I20171107001415 |
News Archive
Methotrexate (MTX) is commonly used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.
Genes of one organism not only control the characteristics of that individual but also dictate the behavior of thousands of other organisms in a community.
Older people in Japan have an "attitude of gratitude" which keeps them feeling hopeful despite the challenges of aging, a new study says.
MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded as part of the Affordable Care Act, apply to small-company R&D expenditures that reduce the cost and increase the quality of healthcare in the U.S. The grants will be applied to the development of MicroPhage's first product, the MRSA/MSSA Blood Culture Test, currently under review at the FDA.
Avita Medical Ltd., the regenerative medicine company, announced today that it has launched ReCell Spray-On Skin for the treatment of chronic leg ulcers, a market estimated at over US$1 billion.
› Verified 9 days ago
| Provider Name | Elana R Guy |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1619168291 PECOS PAC ID: 8820364037 Enrollment ID: I20171108002212 |
News Archive
Methotrexate (MTX) is commonly used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.
Genes of one organism not only control the characteristics of that individual but also dictate the behavior of thousands of other organisms in a community.
Older people in Japan have an "attitude of gratitude" which keeps them feeling hopeful despite the challenges of aging, a new study says.
MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded as part of the Affordable Care Act, apply to small-company R&D expenditures that reduce the cost and increase the quality of healthcare in the U.S. The grants will be applied to the development of MicroPhage's first product, the MRSA/MSSA Blood Culture Test, currently under review at the FDA.
Avita Medical Ltd., the regenerative medicine company, announced today that it has launched ReCell Spray-On Skin for the treatment of chronic leg ulcers, a market estimated at over US$1 billion.
› Verified 9 days ago
| Provider Name | Ann Keilman |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1912550310 PECOS PAC ID: 8426424144 Enrollment ID: I20221021000447 |
News Archive
Methotrexate (MTX) is commonly used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.
Genes of one organism not only control the characteristics of that individual but also dictate the behavior of thousands of other organisms in a community.
Older people in Japan have an "attitude of gratitude" which keeps them feeling hopeful despite the challenges of aging, a new study says.
MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded as part of the Affordable Care Act, apply to small-company R&D expenditures that reduce the cost and increase the quality of healthcare in the U.S. The grants will be applied to the development of MicroPhage's first product, the MRSA/MSSA Blood Culture Test, currently under review at the FDA.
Avita Medical Ltd., the regenerative medicine company, announced today that it has launched ReCell Spray-On Skin for the treatment of chronic leg ulcers, a market estimated at over US$1 billion.
› Verified 9 days ago
News Archive
Methotrexate (MTX) is commonly used to treat rheumatoid arthritis (RA) and is suggested as the "anchor" drug in treating the disease.
Genes of one organism not only control the characteristics of that individual but also dictate the behavior of thousands of other organisms in a community.
Older people in Japan have an "attitude of gratitude" which keeps them feeling hopeful despite the challenges of aging, a new study says.
MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded as part of the Affordable Care Act, apply to small-company R&D expenditures that reduce the cost and increase the quality of healthcare in the U.S. The grants will be applied to the development of MicroPhage's first product, the MRSA/MSSA Blood Culture Test, currently under review at the FDA.
Avita Medical Ltd., the regenerative medicine company, announced today that it has launched ReCell Spray-On Skin for the treatment of chronic leg ulcers, a market estimated at over US$1 billion.
› Verified 9 days ago
Center For Social Dynamics Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1025 Atlantic Ave, 101, Alameda, CA 94501 Phone: 510-268-8120 | |
Henry T Freeland Med Corp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 512 Westline Dr, Suite 203, Alameda, CA 94501 Phone: 510-521-4323 Fax: 510-521-5623 | |
Psychtools Psychology Group P.c. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1402 Park St, Suite G, Alameda, CA 94501 Phone: 510-900-5123 | |
A Better Way, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 401 Pacific Ave, Alameda, CA 94501 Phone: 510-433-8600 Fax: 510-485-7173 | |
Alameda Family Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 500 Pacific Ave, Alameda, CA 94501 Phone: 510-748-4024 | |
Athmindset Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1104 Marianas Ln, Alameda, CA 94502 Phone: 510-206-6095 | |
Alameda Family Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 351 Jack London Ave # 401a405a, Alameda, CA 94501 Phone: 510-748-4006 |